Digital Currencies – If you are awake and reading this, you heard that BTC hit $50k over the weekend. Congrats, apes, we made it back, hitting this all-important level for the first time since mid-May. Perhaps even more importantly, on a long term technical basis, much stronger support levels have been formed in the $30k — $35k range, suggesting the next downturn will have a tough time reaching and breaking those levels. Of course, this also means that if those levels are broken in another downturn, that downturn could become much...much worse. Either way, let's enjoy it while it lasts as the asset class rebounds once more.

Trillium Therapeutics ($TRIL) – The big winner of the American stock market yesterday was none other than Trillium Therapeutics, booming up 188.8%. The nearly 3x increase in price comes after the announcement that Pfizer will be acquiring the cancer therapy developer for $2.3bn, further diversifying their line of pharma products to wildly overcharge you for.

mRNA Vaccines – The win of wins everyone has been waiting for finally came today, with the FDAs full approval granted to Pfizer’s vaccine. This marks the first mRNA vaccine to have full approval from the FDA, a groundbreaking moment for the new biotechnology that has potential to tackle a plethora of other diseases, from AIDS to the common flu. On this news, the kingpins of mRNA got a well-deserved bump in share price, with Pfizer rising 2.5% and Moderna up 7.6%.